Clinical Trial Update: HD10 for Early Stages [Phase 3]

View source ↗

Summary

Sponsored by the University of Cologne, the Phase 3 trial HD10 for early-stage Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• HD10

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin´s Lymphoma | Phase 3 | Status: COMPLETED